T. Brier

发表

Central arteriovenous anastomosis for hypertension: it is not all about sympathomodulation.

Ajay K. Jain, M. Lobo, T. Brier, 2015, Future cardiology.

A Novel Alpha-Synuclein Missense Mutation in Parkinson's Disease

A. Schapira, J. Cooper, H. Houlden, 2012 .

First-in-man treatment of severe blood pressure variability with baroreflex activation therapy.

M. Adeel, N. Sutcliffe, D. Collier, 2016, International journal of cardiology.

Lichen planus and lichenoid dermatoses: Conventional and emerging therapeutic strategies.

J. McGrath, D. Fenton, C. Tziotzios, 2018, Journal of the American Academy of Dermatology.

Lichen planus and lichenoid dermatoses: Clinical overview and molecular basis.

J. McGrath, D. Fenton, C. Tziotzios, 2018, Journal of the American Academy of Dermatology.

Comment on renal denervation versus carotid sinus stimulation

P. Pilowsky, P. Marvar, V. Kapil, 2015 .

Contrasting actions of philanthotoxin-343 and philanthotoxin-(12) on human muscle nicotinic acetylcholine receptors.

P. Usherwood, P. Krogsgaard‐Larsen, J. Jaroszewski, 2003, Molecular pharmacology.

A novel α-synuclein missense mutation in Parkinson disease

Christos Proukakis, Henry Houlden, A. Schapira, 2013, Neurology.

Monoclonal Antibodies: Past, Present and Future.

A. Datta-Mannan, J. Posner, T. Brier, 2019, Handbook of experimental pharmacology.

Analysis of Parkinson's disease brain–derived DNA for alpha-synuclein coding somatic mutations

E. Tolosa, A. Schapira, N. Wood, 2014, Movement disorders : official journal of the Movement Disorder Society.

Analysis of Parkinson's disease brain–derived DNA for alpha-synuclein coding somatic mutations

E. Tolosa, A. Schapira, N. Wood, 2014, Movement Disorders.

Solid-phase synthesis and biological evaluation of a combinatorial library of philanthotoxin analogues.

P. Usherwood, P. Krogsgaard‐Larsen, J. Jaroszewski, 2000, Journal of medicinal chemistry.

Modification of the philanthotoxin-343 polyamine moiety results in different structure-activity profiles at muscle nicotinic ACh, NMDA and AMPA receptors

P. Usherwood, P. Krogsgaard‐Larsen, J. Jaroszewski, 2003, Neuropharmacology.

Abstract PS11-05: Updated data from SERENA-1: A Phase 1 dose escalation and expansion study of the next generation oral SERD AZD9833 as a monotherapy and in combination with palbociclib, in women with ER-positive, HER2-negative advanced breast cancer

A. Cohen, U. Banerji, P. Kabos, 2021 .

A phase I dose escalation and expansion study of the next generation oral SERD AZD9833 in women with ER-positive, HER2-negative advanced breast cancer.

U. Banerji, C. Twelves, R. Baird, 2020 .

Abstract CT141: Phase 1 trial of MOv18, a first-in-class IgE antibody therapy for cancer

Kristina M. Ilieva, S. Pinder, U. Banerji, 2020, Tumor Biology.

Central arteriovenous anastomosis for hypertension: it is not all about sympathomodulation.

M. Lobo, T. Brier, A. Jain, 2015, Future cardiology.

A Discussion on the Regulation of Blood Flow and Pressure.

D. Collier, V. Kapil, M. Lobo, 2016, Advances in Experimental Medicine and Biology.